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~ ,raying.23 For example, in the Solomon Islands, the cost of 
I DT is over three times that of bednets.11 In Vietnam, on the 
c her hand, lamda-cyhalothrin house spraying cost US$0.43 
I ;s than bednets per person per year." In Afghanistan, 
r alathion house spraying was cheaper than permethrin-
t cated bednets,11 while in Tanzania23 bednets were cheaper 
t an house spraying. In order to advise the Department of 
l ealth in South Africa reliably, data on the cost eftectiveness of 
t odnets versus house spraying and the longer-term monitoring 
l this intervention are essential. 
The authors thank Christian Lengeler for critically appraising 
t IS manuscript and the South African Medical Research Council, 
t 2 Department of Health KwaZulu- a tal and the Rotary 
I :emational Kitchener-Connestoga Club, Ontario, Canada for 
and al support. 
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THE INCREASING BURDEN OF 
TUBERCULOSIS IN PREGNANT 
WOMEN, NEWBORNS AND 
INFANTS UNDER 6 MONTHS OF 
AGE IN DURBAN, KWAZULU-
NATAL 
T Pillay, M Khan, J Moodley, M Adhika.ri, N Pa.da.yatchi, 
V Na.icker, D G Pilla.y, H M Coova.dia. 
Objectives. In spite of the global epidemic of tuberculosis (TB) 
which has been exacerbated by HIV, the impact of these co-
infections on maternal and perinatal health has been limited. 
We document new evidence from Durban, KwaZuJu- a tal, 
on the increasing effects of TB in pregnant women, neonates 
and infants. 
Method. Women with TB were prospectively tudied at the 
antenatal clinics and obstetric and labour wards at King 
Edward VIll Hospital, Durban, between 1996 and 1998. The 
incidence of TB was calculated, and the population-
attributable fraction of TB due to HIV infection in pregnancy 
was estimated. Concurrently, culture-confirmed cases of 
Mycobacterium tubaculosis in neonates and infants under 6 
months of age at the hospital were documented . 
Results. One hundred and forty-six cases of maternal TB w re 
detected. TB occurred in 0.1% and 0.6% of maternities in 1996 
and 1998 respectively. Overall, TB rate for HIV non-infected 
maternities was 72.9/ 10', and for HIV-infected materniti , 
774.5/ 10'. The attributable fraction of TB related to HIV in 
pregnancy was 71.7%; 10.3% of these mothers died . There 
was a 2.2-fold increase in the caseload of culture-confirmed 
TB in neonates and young infan ts at the hospital. 
Conclusion. In regions where TB and HJV preval nee is high, 
efforts to improve maternal and perinatal health must 
include the detection of TB in pregnancy. 
S lrfr Med /2001; 91: m-987. 
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ORIGINAL ARTICLES 
Maternal diseases account for 2.2% of the disability-adjusted 
life years in the global burden of disease,' and the largest 
proportion of deaths in women of reproductive age occur in 
relation to pregnancy.2 This burden of death and disease occurs 
mostly in developing countries and includes among its leading 
causes hypertension, haemorrhage and sepsis.3 HIV and 
tuberculosis (TB) have been major causes of adult death and 
disease in the developing world; but their joint contribution to 
maternal morbidity and mortality has been sparsely 
documented .... Neonatal and early infant TB are usually 
acquired through maternal TB and have also been poorly 
documented within the context of HIV infection. TB is 
infrequently detected among infants born to HIV-seropositive 
women,10 and has rarely been described in HIV-infected 
neonates." In this report from KwaZulu-Natal we describe the 
increasing burden of TB, in association with HIV, on maternal 
health in the region. In addition, we document neonatal and 
early infant TB under 6 months of age as surrogate indicators 
of latent, active or undetected maternal disease. 
PATIENTS 
Pregnant women 
Pregnant women with TB, detected at the antenatal clinics and 
labour ward at King Edward VIll Hospital (KEH) in Durban, 
South Africa, between January 1996 and December 1998, were 
prospectively studied. All of the mothers recruited presented 
with clinical signs and symptoms of disease, and TB was 
diagnosed by: (i) detection of acid-fast bacilli on sputum-smear 
microscopy; (ii) culture of Mycobacterium tuberculosis; 
(iiz) histological evidence of tuberculous disease; and/ or 
(iv) radiological features supporting TB in the mother. A 
maternal endometrial sample for TB culture was submitted 
where congenital TB was suspected. HIV antibody status of the 
mothers was determined by HIV-1 EUSA (Abbot, Wiesbaden, 
Germany), following both pre- and post-test counselling 
conducted by a trained HIV counsellor. Maternal clinical 
profiles and deaths were documented. 
Neonates and infants 
During the same time period, the number of neonates and 
infants under 6 months of age with culture-confirmed TB at the 
hospital was recorded. For neonates these data were collected 
prospectively, and for infants the data were obtained 
retrospectively from the hospital's microbiology database. 
These neonates and infants did not necessarily represent 
mother-baby pairs. Teonates were investigated for TB if: (1) the 
mother had TB during pregnancy; or (ii) the neonate had a 
progressive pneumonia, and/or unexplained visceromegaly." 
For neonates and infants, investigation for TB included three 
early-morning gastric aspirates buffered in a 1% sodium 
bicarbonate solution and submitted for smear microscopy and 
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culture forM. tuberculosis, and chest radiography. Additional 
investigations, such as cerebrospinal fluid culture and biopsy 
samples, were undertaken when clinically indicated. 
METHODS 
HIV-1 seroprevalence rate 
Some of the women who delivered at the hospital had receivt d 
antenatal care at KEH, some had received antenatal care at 
other primary and secondary health care centres in the regior 
and some had received no antenatal care before delivery. 
Although all mothers using the hospital's antenatal facilities 
were offered HIV testing with counselling, this service was n 
routinely available at other antenatal centres within the great r 
Durban area during this study period, and peripartum HIV 
screening was not standard practice at KEH labour ward . As 
result, although the hospital recorded 50 518 maternities, it "' IS 
not possible to determine the exact number of HIV-infected 
maternities during the study period. We therefore estimated 
the total number of HIV-infected maternities based on the 
following documented statistics: (z) the total number of 
deliveries per year s~died in 1996, 1997 and 1998, namely IE 
908, 16 811 and 16 799 respectively; (ii) 25%, 28% and 30% HJ 1 
seroprevalence rates for 1996, 1997 and 1998 among antenata 
attendees respectively (Department of Obstetrics and 
Gynaecology, and KEH Virology statistics - unpublished 
data); and (iii) a 10% unhooked rate- among these women 
HIV-1 seroprevalence rates were 45%.12 
Statistical calculations 
The caseload of TB in pregnant women, neonates and infantf at 
the hospital was estimated. Hospital-specific infection rates f •r 
TB in pregnancy were calculated. The attributable fraction (t F) 
of TB related to HIV infection in pregnancy was calculated 
using the formula: AF exposure = 1-1 / RR, and AF population = AF, X 
PE (prevalence of exposure). RR was the relative risk of TB-
HIV co-infection v. TB without HIV infection in pregnancy, a 1d 
PE was the fraction of TB-HIV co-infected mothers of the tot~ I 
mothers with TB in pregnancy. Analysis was performed usin~ 
Epi-Info Version 6.02 (Centers for Disease Control, Atlanta, 
Georgia); categorical data were analysed using the chi-square 
test, and exact binomial confidence intervals (Cis) were 
calcula ted for proportions. 
RESULTS 
TB in pregnancy 
One hundred and forty-six women were diagnosed with TB 
during pregnancy; the overall hospital rate of TB was 289.0 per 
100 000 maternities. TB accounted for 11 of 16 908 deliveries 
(0.1 %) in 1996 and 94 of 16 799 deliveries (0.6%) in 1998 
(Fig. 1). Of these mothers with TB, 115 (78.8%, 95% CI 71.2 -
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1 g. 1. Case/oad ofTB and TB-HIV co-infection in pregnant women 
. 'ending King Edward VIII Hospital, 1996- 1998. 
1%) were HIV-infected, 26 (17.8%, 95% CI 12.0- 25.0%) were 
V-non-infected, and in 5 mothers HIV status was not 
c termined. Minimum TB-HIV co-infection rates increased 
m 36.4% in 1996 to 88.3% in 1998 (P < 0.001, Fig. 1). 
Based on our calculations, 14 849 of the 50 518 parturients 
1 re HIV-infected. The TB prevalence rate for HIV-non-
ected maternities at the hospital was 72.9/100 000, and for 
V-infected maternities, 774.5/100 000. The relative risk of TB 
d e to HIV infection was 774.5/72.9 = 10.62 (95% CI 6.9- 16.3). 
l ~ AFexposure was therefore 1-1/10.62 = 0.91 and the 
' population = 0.91 x 78.8 = 71.7%, i.e. the population-
a ributable fraction of TB related to HIV infection in pregnant 
1' ·men was 71.7%. 
Jiagnosis and type of TB in the mothers are described in 
T ale I. Pulmonary TB (PTB) was the commonest form of TB, 
o :uning in 115/146 (78.8%); there was no statistical difference 
b 'Ween the rates of PTB among HIV-infected women and their 
non-infected counterparts. Similarly, there was no difference 
between the rates of sputum smear microscopy positi\ity 
between the two groups. Sixty-three per cent of the mothers 
had TB detected within the last 3 months of pregnancy. o 
significant difference in the prevalence of extra pulmonary TB 
was detected between the HIV-infected and non-infected 
cohorts. Two mothers, one in each category, had multidrug-
resistant TB. Fifteen mothers with TB died during the study 
period, resulting in a mortality rate of 103 deaths per 1 000 
women with overt TB during pregnancy. Fourteen of these 
women (93.3%) were HIV-co-infected." 
Neonatal and infant tuberculosis 
Thirty-five neonates and 59 infants had culture-confirmed TB 
during this time period. In only 13 of the neonates (37.1%) was 
maternal TB diagnosed before detection in the neonate. Fig. 2 
describes the progression in the number of culture-confirmed 
cases of TB in neonates and infants under 6 months of age at 
KEH. There was a 2.2-fold increase in TB detected in newborn 
babies and infants between 1996 and 1998, from 20 (21.2% of 
total cases) in 1996 to 43 (45.7% of total cases) in 1998. Most of 
the newborns (85.7%) and infants (83.1%) were smear-negative, 
with median time of culture confirmation 6 weeks. In 95.7% of 
cases the organism was susceptible to first-line anti-TB drugs; 4 
babies had multidrug-re istant TB. Median age of detection of 
TB in infants in the 1 - 6-month age category was 2.5 months 
(standard deviation (SO) 1.8). HIV distribution in the infants 
was not calculated as this component was undertaken 
retrospectively and complete follow-up datasets were not 
available for these infants. HIV infection status in the neonates 
is currently being evaluated in a longitudinal follow-up study 
at the unit. 






Extra pulmonary TB 
Pleural effusion 
MiliaryTB 
C S/spinal TB 
Genital/abdominal TB 
Lymph node TB 
Constrictive pericarditis 
HIV-infected (%) 











·Tuberculous granulomas on bronchoscopic biopsy .sample. 
AFB = add-fast bacilli; CNS = central nervous system-
HIV-non-infected (%) 



















30 0 Neonatal TB 









1996 1997 1998 
Year 
Fig. 2. Culture-confirmed TB in neonates and infants less than 6 
months of age in the paediatric _wards, neonatal and mtenszve care 
units, King Edward VIII Hospztal, 1996- 1998. 
DISCUSSION 
In this study we draw attention to the major impact of TB, 
when it occurs together with HIV, on the reproductive health of 
women in South Africa. In the recent extensive literature on TB 
and HIV, with the latter fuelling the epidemic of the former, the 
impact of TB on pregnant women, their newborn babies and 
infants has not been adequately documented. In this study we 
have shown a dramatic increase in the caseload of TB in 
pregnancy between 1996 and 1998,71.7% of which was 
attributable to HIV. This increase was paralleled by a rise in 
incidence of newborn and infant TB at the hospital. 
Our findings parallel the global finding of increase in TB 
incidence over the last two decades,••and the increase in TB in 
women of childbearing age in our region. In rural KwaZulu-
Natal, TB among women (mean age 33.4 years) increased from 
15 
28% to 37% between 1991 and 1995; and a 157.5%'6 - 400%17 
increase in the ~umber of TB-related deaths in women in their 
thirties was doc-Llill.ented in conjunction with the escalating 
HIV epidemic in this province." 
HIV and TB target women in their prime childbearing years, 
and co-infection has been widely reported, reaching a peak of 
65% in adults in our region.'• Consequently, one would have 
anticipated an increase in reports of TB and HIV co-infection in 
pregnant women, especially in sub-Saharan Africa, since this 
region carries the brunt of TB and HIV infection in adults 
globally.• However, this has not been the case. TB has not been 
documented in major HIV cohort studies from Africa or the 
developed countries.'" Only two studies in the USA have 
reported on maternal TB in relation to HIV infection: The 
Women and Infants Transmission Study in the USA19 
documented 11 of 52 pregnant women with a positive 
tuberculin skin test of more than 5 mm or medical history of 
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TB, and Margono and colleagues"' reported HIV infection in 7 
of 11 tested women (64%) with TB in pregnancy. In Africa, 
reports suggest an increased risk of TB in HIV-infected wome 1 
post delivery (Nairobi and Rwanda). 1021.n More recently, Ahmc d 
and colleagues• reported TB as a major cause of non-obstetric-
related mortality in Zambia. 
Historical·data have revealed uncertainties about the impact 
of TB on reproductive health.23 However, recent studies from 
the Third World detail consistently increased perinatal and 
obstetric complications: TB in pregnancy has been associated 
with a 6-fold increase in perinatal deaths, a 2-fold increase in 
perinatal morbidity and a maternal mortality rate of 66 per 
1 000 pregnant women infected with TB.''"26 Early treatment o 
TB in pregnancy improves obstetric and perinatal outcome." 
However, routine antenatal care (ANC) services may not be 
sensitised to the early detection of TB in the Third World. 
Moreover, women often attend ANC services late in pregnan. f 
in Africa. At KEH, the mean age of antenatal booking is 28 
weeks; therefore the window of opportunity for the detectior 
of TB disease before labour is small. Also, the presentation of 
TB in pregnancy may vary from asymptomatic to nonspecific 
mimicking the physiological signs of pregnancy. Our data 
failed to show an increase in extra pulmonary TB in HIV-
infected pregnant women, and are similar to those from the 
pre-HIV era which noted a 10- 24.4%27.28 extrapulmonary TB 
rate in pregnancy. As the detection of genital TB requires 
detailed placental and endometrial tissue analysis, it is possi~ e 
that our figures underrepresent the true extent of undetected 
extrapulmonary and genital TB in our region. Our cases of 
neonatal TB without concordance with maternal disease 
(62.9%) support this hypothesis. 
Although there are adverse perinatal outcomes, and 
mortality, from whatever cause is high in pregnancies 
complicated by TB and HIV co-infection, it is difficult at this 
stage to recommend any specific antenatal prevention strateg "~ 
without further study. Such interventions are most likely to b~ 
effective if they are coupled with programmes aimed at 
interruption of mother-to-child transmission of HIV. A meth J 
for determining women at greatest risk for developing TB 
during pregnancy needs to be established. Also, if it is true that 
pregnancy potentiates re-activation or re-infection with TB 
within the index pregnancy, prophylactic regimens including 
isoniazid for a fixed duration may be indicated in an attempt to 
reduce adverse maternal and perinatal outcomes. 
This study represents only women with overt TB in 
pregnancy detected at KEH. These figures may not reflect the 
true prevalence in the general urban and semi-urban 
population around the greater Durban area. It is difficult to 
gauge the extent of missed cases in other health facilities in our 
region as pregnancy is not a recognised category on South 
African TB notification forms. Regardless, the combined 
escalation of TB incidence in pregnancy, newborns and young 
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il ants requires heightened awareness from all health care 
" >rkers in the region. 
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MICROVASCULAR 
COMPLICATIONS IN SOUTH 
AFRICAN PATIENTS WITH LONG-
DURATION DIABETES MELLITUS 
Ayesha A Motala, Fraser J Pirie, Eleanor Gouws, 
Aslam Amod, Mahomed A KOmar 
Objective. To determine the prevalence of microvascular 
complications in South African black and Indian patients 
with long-duration diabetes mellitus (DM). 
Design. A retrospective analysis was undertaken of clinical 
records of 219 DM patients (132 black, 87 Indian) with long-
duration DM (over 10 years) attending a diabetes clinic in 
Durban. Data recorded on each subject included 
demographic details (age, gender, ethnic group, type of 
diabetes, age of onset and duration of diabetes), presence of 
retinopathy, markers of nephropathy and biochemical 
variables. The prevalence of complications and the clinical 
and biochemical parameters were evaluated for type 1 and 
type 2 diabetes and for each ethnic group. 
Results. Of the 219 patients, 47 had type 1 DM (36 blacks, 11 
Indians) and 172 were classilied a type 2 DM (96 blacks, 76 
Indians). The mean age of onset of DM wa later in blacks 
than Indians, both for type 1 (P < 0.05) and type 2 DM (P < 
0.01). In patient with type 1 DM, the prevalence of 
retinopathy was 53.2% (blacks 55.6%, lndians 45.5%}, 
persistent proteinuria was found in 23.4% (blacks 25%, 
Indians 1 .2%) and hypertension in 34%. o ethnic difference 
was found except for the prevalence of hypertension which 
was higher in blacks than Indians (41.7% v. 9.1%, P < 0.5). 
Onset of retinopathy from time of diabetes diagno i 
occurred earlier in blacks than Indians (13.0 ± 4.6 yr v. 18.0 ± 
4.6 yrs, P < 0.05). For the type 2 DM group, r tinopathy was 
found in 64.5% (black v. Indian 68.8 v. 59.2%) and per istent 
proteinuria in 25% (black v. Indian 30.2 v. 1 .4%). 
Hyperten ion was observed in 68% and wa more prevalent 
in blacks (84.4 v. 47.4%, P < 0.01} There was an earlier onset 
of retinopathy (P < 0.05) and hypertension (P < 0.01) from 
time of diabetes diagno is in blacks than Indians. In the type 
1 DM group retinopathy was associated with a ignificantly 
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